High CSF Tau-protein concentration in delirium induced by high dose psychiatric medication.
Windhagen
Anja
A
Wurster
Ulrich
U
Kropp
Stefan
S
Ziegenbein
Marc
M
D000341:Affective Disorders, Psychotic / Q000134:cerebrospinal fluid / Q000175:diagnosis / Q000188:drug therapy*; D000544:Alzheimer Disease / Q000134:cerebrospinal fluid / Q000175:diagnosis / Q000523:psychology; D000928:Antidepressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003072:Cognition Disorders / Q000134:cerebrospinal fluid / Q000139:chemically induced; D003693:Delirium / Q000134:cerebrospinal fluid / Q000139:chemically induced*; D003865:Major Depressive Disorder / Q000134:cerebrospinal fluid / Q000175:diagnosis / Q000188:drug therapy*; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008318:Malpractice; D008376:Maprotiline / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D016875:tau Proteins / Q000134:cerebrospinal fluid*
D000928:Antidepressive Agents; D018687:Antidepressive Agents, Second-Generation; D014150:Antipsychotic Agents; D016875:tau Proteins; D008376:Maprotiline